Pembrolizumab (pembro) plus docetaxel and prednisone in patients with abiraterone acetate (abi)- or enzalutamide (enza)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort B update
Dokumenttyp:
Meeting Abstract
Autor(en):
Romano, E.; Sridhar, S. S.; Kolinsky, M. P.; Gravis, G.; Mourey, L.; Piulats, J. M.; Berry, W. R.; Gurney, H.; Retz, M.; Appleman, L. J.; Boegemann, M.; de Bono, J. S.; Joshua, A. M.; Emmenegger, U.; Conter, H. J.; Laguerre, B.; Wu, H.; Qiu, P.; Schloss, C.; Yu, E. Y.